📰 Eric Roeland News
Page 2 - Eric Roeland News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Eric Roeland. Real-time updates on events, politics, business and more.
May 10, 2022
Mytesi® net revenue of $2.6 million increased approximately 24% over the fourth quarter of 2021 and increased approximately 112% over Mytesi net revenue in the first quarter of 2021Core initiatives:OnTarget
May 20, 2021
(0) SAN FRANCISCO, CA / ACCESSWIRE / May 20, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced the highlights of the abstract regarding patient outcomes associated with cancer-related diarrhea ("CRD") by Napo Pharmaceuticals, Inc. ("Napo"), Jaguars wholly owned subsidiary, and Napos collaborators that has been accepted for poster presentation at the American Society of Clinical Oncology (ASCO ®) Annual Meeting, which will be held virtually from June 4-8, 2021...
May 20, 2021
Jaguar Health and Napo Pharmaceuticals Provide Key Findings from Cancer-related Diarrhea Abstracts Submitted to ASCO for June 2021 Annual Meeting ACCESSWIRE 20 May 2021, 22:43 GMT+10 SAN FRANCISCO, CA / ACCESSWIRE / May 20, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar or the Company) today announced the highlights of the abstract regarding patient outcomes associated with cancer-related diarrhea (CRD) by Napo Pharmaceuticals, Inc. (Napo), Jaguars wholly owned subsidiary, and Napos collabora...
April 29, 2021
(0) SAN FRANCISCO, CA / ACCESSWIRE / April 29, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced the title of the abstract regarding patient outcomes associated with cancer therapy-related diarrhea ("CTD") by Napo Pharmaceuticals, Inc. ("Napo"), Jaguars wholly owned subsidiary, and Napos collaborators that has been accepted for poster presentation at the American Society of Clinical Oncology (ASCO ®) Annual Meeting, which will be held virtually from June 4-8, 2021. The title of the acce...